Aura Biosciences, Inc. (AURA) stock
AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.14−0.01 (-0.14%)
Close on Nov 18, 2026Market cap $740.45MP/E –Yield –
Aura Biosciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Aura Biosciences
Aura Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?